Back

Aspirin for primary cardiovascular prevention: is there a need for risk stratification?

European Heart Journal

21 April 2019
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY BASIC SCIENCE Pharmacology and Pharmacotherapy

Contributors

Alberto Aimo
Alberto Aimo

Author

Raffaele De Caterina
Raffaele De Caterina

Author

University of Pisa Pisa , Italy

You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
CT-based cardiovascular risk stratification benefits in asymptomatic patients
9 May 2021
thumbnail
Congress Presentation
Statins for primary prevention among elderly men and women.
27 August 2021
thumbnail
Congress Presentation
Prevalence and characteristics of low-dose acetylsalicylic acid intake in the German population: insights from the German National Cohort (NAKO)
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources